Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“ Afya ” or the “ Company ”), the leading medical education group and provider of medical practice solutions in Brazil,...
Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”) , the leading medical education group and medical practice solutions provider in Brazil, announced today that Mrs. Maria...
Impressive Adjusted EBITDA Margin Expansion and Cash Generation Full Year 2025 Guidance Reaffirmed
Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, today announced that the Secretary...
Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company ” ) , the leading medical education group and medical practice solutions provider in Brazil, announced today...
Bank of America Securities analyst Flavio Yoshida maintained a Buy rating on Afya on October 10 and set a price target of $25.50. The company’s shares closed last Friday at $14.39.Elevate Your Investing...
Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Afya ( (AFYA)...
Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company ” ) , the leading medical education group and medical practice solutions provider in Brazil, announced today...